# DAPAGLIFLOZIN
> **ANDA211564** · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK GENERICS · Approved 2020-03-20
## Drug
- **FDA Application Number:** ANDA211564
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DAPAGLIFLOZIN
- **Generic name:** Dapagliflozin
- **Active ingredients:** DAPAGLIFLOZIN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** GLENMARK GENERICS
- **First approval:** 2020-03-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211564)
---
*MORVS · CC0 1.0*